The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-tert-Butyl-N-(4-hydroxynaphthalen-1-yl)benzenesulfonamide ID: ALA3360257
Cas Number: 301315-29-7
PubChem CID: 1106000
Max Phase: Preclinical
Molecular Formula: C20H21NO3S
Molecular Weight: 355.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(O)c3ccccc23)cc1
Standard InChI: InChI=1S/C20H21NO3S/c1-20(2,3)14-8-10-15(11-9-14)25(23,24)21-18-12-13-19(22)17-7-5-4-6-16(17)18/h4-13,21-22H,1-3H3
Standard InChI Key: BKEZPAKTGANESH-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
1.2712 -6.1785 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6839 -6.8883 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.0923 -6.1760 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9782 -7.3011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3936 -7.3011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1013 -6.8925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2683 -6.8933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4380 -7.3053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4338 -8.1238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2824 -8.5284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9848 -8.1141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5153 -6.0795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8027 -5.6711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0983 -6.0813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1405 -8.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8497 -8.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1379 -9.3544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8490 -8.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5149 -6.8976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8091 -7.3037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8089 -8.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5138 -8.5235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2204 -8.1123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2170 -7.3012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2225 -5.6700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 1 0
4 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 4 1 0
6 20 2 0
19 12 2 0
12 13 1 0
13 14 2 0
14 6 1 0
9 15 1 0
15 16 1 0
15 17 1 0
15 18 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
12 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.46Molecular Weight (Monoisotopic): 355.1242AlogP: 4.64#Rotatable Bonds: 3Polar Surface Area: 66.40Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.85CX Basic pKa: ┄CX LogP: 4.69CX LogD: 4.57Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: -1.06
References 1. Jung HJ, Cho M, Kim Y, Han G, Kwon HJ.. (2014) Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads., 57 (19): [PMID:25244355 ] [10.1021/jm500863j ] 2. (2017) Arf6 inhibitors and methods of synthesis and use thereof,